First Trust Advisors
QTTB icon

First Trust Advisors’s Q32 Bio QTTB Stock Holding History

First Trust Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$737K Buy
+89,134
New +$1.23M ﹤0.01% 2339

Other funds holding QTTB

Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

First Trust Advisors's QTTB Position: Q3 2026 in Review

First Trust Advisors opened a new position in Q32 Bio (QTTB) in Q3 2026: 89,134 shares worth $737K. The stake represents ﹤0.01% of the portfolio and ranks #2339 among its holdings.

39 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.

  • First Trust Advisors held 89,134 shares of Q32 Bio worth $737K as of Q3 2026.
  • Q32 Bio was a new First Trust Advisors position in Q3 2026.
  • Q32 Bio made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #2339 holding.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.

Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.